NEW YORK (GenomeWeb) – Bioinformatics firm BioDiscovery and genomic service provider Akesogen today announced a co-marketing deal, which they said will provide customers a complete end-to-end solution for cytogenomic array and next-generation sequencing services. 

Financial and other terms of the deal were not disclosed. 

As part of the agreement, samples obtained from Akesogen's laboratory will be analyzed with BioDiscovery's software solutions, "allowing users to easily process their samples and convert raw data into meaningful results," the partners said in a statement. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.